Analysed TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) News Sources
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
15-05-2026
yahoo.com
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing
18-05-2026
yahoo.com
Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences
27-05-2026
yahoo.com
Is Telix (ASX:TLX) Quietly Assembling a Connected Oncology Platform That Reshapes Its Moat?
28-05-2026
yahoo.com
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026
01-06-2026
yahoo.com
Telix Pharmaceuticals (TLX), United Imaging Healthcare Form Strategic Theranostics Research Partnership
17-06-2026
yahoo.com
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
22-06-2026
yahoo.com
What is the current price of TELIX PHARMACEUTICALS LTD (TLX:NASDAQ)?
The current price of TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) is $11.14.
TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) since the previous trading day is $-0.64.
TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) since the previous trading day is -5.4329%.
What is the most recent average sentiment score for TELIX PHARMACEUTICALS LTD (TLX:NASDAQ)?
The most recent average sentiment score for TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for TELIX PHARMACEUTICALS LTD (TLX:NASDAQ)?
The most recent sentiment for TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) is .
SEC-8K** Filing Available For TELIX PHARMACEUTICALS LTD (TLX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.